Acadian Asset Management
CKPT

Acadian Asset Management’s Checkpoint Therapeutics CKPT Stock Holding History

Acadian Asset Management’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,969
Closed -$214K – 2214
2020
Q3 		$214K Sell
7,969
-3,534
-31% -$84.9K ﹤0.01% 1430
2020
Q2 		$227K Sell
11,503
-526
-4% -$9.58K ﹤0.01% 1443
2020
Q1 		$182K Buy
12,029
+3,417
+40% +$60.5K ﹤0.01% 1221
2019
Q4 		$148K Buy
8,612
+5,136
+148% +$86K ﹤0.01% 1358
2019
Q3 		$87K Buy
3,476
+705
+25% +$19.3K ﹤0.01% 1518
2019
Q2 		$84K Buy
+2,771
New +$109K ﹤0.01% 1400

Other funds holding CKPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Acadian Asset Management's CKPT Position: Q4 2020 in Review

Acadian Asset Management sold out of Checkpoint Therapeutics (CKPT) in Q4 2020, closing a stake of 7,969 shares — an estimated $214K sold.

Acadian Asset Management first reported a position in CKPT in Q2 2019 and held it in 6 quarters. The position peaked at $227K in Q2 2020. 62 funds tracked by Wall St. Rank hold CKPT as of Q4 2020.

  • Acadian Asset Management reported no remaining Checkpoint Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Acadian Asset Management sold 7,969 Checkpoint Therapeutics shares in Q4 2020, an estimated $214K.
  • Acadian Asset Management first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 6 quarters.
  • Acadian Asset Management's Checkpoint Therapeutics position peaked at $227K in Q2 2020.
  • 62 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2020.

Based on Acadian Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.